Filing Details

Accession Number:
0001140361-16-083800
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2016-10-27 17:55:28
Reporting Period:
2016-10-25
Filing Date:
2016-10-27
Accepted Time:
2016-10-27 17:55:28
Original Submission Date:
2016-10-27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1428336 Healthequity Inc HQY () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352786 S Manu Rana 280 Park Avenue, 3Rd Floor
New York NY 10017
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-10-25 294,116 $35.85 382,352 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $21.27 2026-02-01 15,000 15,000 Direct
Common Stock Restricted Stock Unit $0.00 795 795 Direct
Common Stock Stock Option (right to buy) $1.25 2021-10-25 7,500 7,500 Direct
Common Stock Stock Option (right to buy) $1.25 2022-04-26 15,000 15,000 Direct
Common Stock Stock Option (right to buy) $1.50 2023-05-09 15,000 15,000 Direct
Common Stock Stock Option (right to buy) $14.00 2024-07-30 15,000 15,000 Direct
Common Stock Stock Option (right to buy) $25.39 2025-03-26 15,000 15,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-02-01 15,000 15,000 Direct
795 795 Direct
2021-10-25 7,500 7,500 Direct
2022-04-26 15,000 15,000 Direct
2023-05-09 15,000 15,000 Direct
2024-07-30 15,000 15,000 Direct
2025-03-26 15,000 15,000 Direct
Footnotes
  1. The number of shares sold was mistakenly reported as 330,882, and the amount of securities beneficially owned following the reported transaction was correspondingly incorrect. The correct number of shares sold, and the correct amount of securities beneficially owned following the reported transaction, are reported here.
  2. Price of $35.85 does not reflect underwriter discount or fees.
  3. All securities are held of record by Financial Partners Fund I, L.P. ("FPF I"), a Delaware limited partnership. The reporting person is a managing principal of FPF I. The reporting person disclaims beneficial ownership of the securities held by FPF I except to the extent of his pecuniary interest therein.
  4. The option became exercisable as to 7,500 shares upon the reporting person's reelection to the issuer's board of directors at the issuer's 2016 Annual Meeting of Stockholders held on June 23, 2016. The remaining 7,500 shares will become exercisable on January 31, 2017; provided, that the reporting person continues to serve as a director of the issuer through such date.
  5. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  6. The restricted stock units vested as to 397 shares on August 1, 2016 and will vest as to the remaining 398 shares on November 1, 2016. Vested shares will be delivered to the reporting person upon the earlier of a change of control of the issuer (as defined in the issuer's 2014 equity incentive plan), or the reporting person's termination of service (as defined in the issuer's 2014 equity incentive plan), or the reporting person's death.
  7. The option is immediately exercisable.